Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. HOOD
8. QCOM
9. ACN
10. AZN

Go back to Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval
(NASDAQ: CLNN) Delayed: 3.62 -0.23 (5.97%)
Previous Close $3.85    52 Week High $ 
Open $3.82    52 Week Low $ 
Day High $3.82    P/E N/A 
Day Low $3.60    EPS $ 
Volume 252,783